Lataa...
New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins
BACKGROUND: Nearly 15% of acute myeloid leukemia (AML) cases are caused by aberrant expression of AML1-ETO, a fusion protein generated by the t(8;21) chromosomal translocation. Since its discovery, AML1-ETO has served as a prototype to understand how leukemia fusion proteins deregulate transcription...
Tallennettuna:
| Julkaisussa: | Front Biol (Beijing) |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5336278/ https://ncbi.nlm.nih.gov/pubmed/28261265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11515-016-1415-1 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|